Capítulo 12. 5. Cuidados intensivos neonatales

Bibliografía
 

1.- Notter RH, Shapiro DL. Sustancias tensioactivas del pulmón como forma de reposición: Aspectos bioquímicos, biofísicos y clínicos. Clin Perinatol, 1987; 3: 433-479. 
2.- Kresch MJ, Gross I. Bioquímica del desarrollo del pulmon fetal. Cli. Perinatol, 1987; 3: 505-525. 
3.- Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 1959; 95: 517-23.
4.- Farrell PM (ed). Lung development: Biological and clinical perspectives.New York. Academic Press, 1982.
5.- Robertson B, Van Golde LMH, Batemburg JJ (eds). Pulmonary surfactant. Amsterdan (The Netherlands). Elsevier, 1984.
6.- Clark DA, Nieman GF, Thompson JE, Paskonik AM, Rokhar JE, Bredemberg CE. Surfactant displacement by meconium free fatty acids. An alternative for atelectasis in meconium aspiration syndrome. J Pediatr, 1987; 110: 765-70. 
7.- Collaborative group in antenatal steroid therapy: Effects of antenatal dexamethasone administration on the prevention of respiratory distress syndrome. Am J Obstet Gynecol 1981; 141: 276-86. 
8.- Collaborative group in antenatal steroid therapy: Effects of antenatal dexamethasone administration in the infant: long term follow-up. J Pediatr, 1984; 104: 259-67. 
9.- Gonzales LW, Ballard PL, Ertsey E. Glucocorticods and thyroid hormone stimulate biochemical and morphological differentation of human lung in organ culture. J Clin Endocrinol Metabol, 1986; 62: 678-91. 
10.- Fujiwara T, Maeta H, Chida S. Artificial surfactant therapy in hyaline membrane disease. Lancet, 1980; i: 55.
11.- Adams FH, Towers B, Osher AB. Effect of tracheal instillation of natural surfactant in premature lambs. Clinical and autopsy findings. Pediatr Res, 1978; 12: 841-45. 
12.- Berry DD. Neonatology in the 1990"s. Surfactant replacement therapy becomes a reality. Clin Pediatr,1991; 3: 167-72. 
13.- Robertson B. Collaborative European Multicentre study group. Factors influencing the clinical response to surfactant replacement therapy in babies with severe respiratory distress syndrome. J Pediatr, 1991; 150: 433-39. 
14.- Collaborative European Multicenter study group. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: An internatonal randomized clinical trial. Pediatrics, 1988; 82: 683-691. 
15.- Long W, Corbet A, Coltans R, Courtney S. A controlled trial of synthetics surfactant in infants weighing 1250 gr or more with respiratory distress syndrome. N Eng J Med, 1991; 12: 1696-703. 
16.- Corbet A and the American Exosurf Pediatric study group. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: A multicenter controlled trial. J Pediatr, 1991; 118: 277-84. 
17.- Kendig JW, Notter RH. Cox C, Reabens LJ. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks gestation. N Eng J Med, 1991; 324: 865-71. 
18.- Phibbs RH, Ballard RA, Clements JA. Initial clinical trial of Exosurf, a protein-free synthetic surfactant, for the prophylaxs and early treatment of hyaline membrane disease. Pediatrics, 1991; 88: 165-69. 
19.- The Osiris collaborative group. Early versus delayed neonatal administration of a synthetic surfactant: the judgement of Osiris. Lancet, 1992: i: 1363-69. 
20.- Surfactant in practice: long-term issues and consequences. Abstract and Work Book. Satellite Symposium X European Congress of Perinatal Medicine, 1992. 
21.- Cummings JJ, Holm BA, Hadak L. A controlled clinical comparison of four different surfactant preparations in surfactant deficient preterm lambs. Am Rev Resp Dis, 1992; 145: 999-1004, 
22.- Clements JA. Lung surfactant compositions. United States Patent 4, 312, 860. January, 1982. 
23.- Van der Bort M, Walther FJ. Cerebral blood flow velocity after surfactant instillation in preterm infants. J Pediatr, 1991; 118: 285-87. 
24.- Soll RS, Meritt TA, Hallman M. Surfactant in the prevention and treatment of respiratory distress syndrome. En: Boynton BR. New therapies for neonatal respiratory failure. Cambridge. University Press, 1994: 49-80. 
25.- Ikegan A. Surfactant inactivation. En: Boynton BR. New therapies for neonatal respiratory failure. Cambridge. University Press, 1994: 36-48.
26.- Quero J, Jiménez J, Aparicio M, Pérez Rodríguez J. Factores determinantes y medidas para mejorar la respuesta al surfactante. An Esp Pediatr, 1995; 73: 115-18.
27.- Kunst J, Reichman B, Neumam I, Shinwell ES. Prognostic value of the immediate response to surfactant. Arch Dis Child ,1994; 71: 170-73. 
28.- Segerer H, Stevens P, Shadow B. Surfactant substitution in ventilated very low birth weight infant. Factors related to response types. Pediatr Res, 1991; 30: 591-96. 
29.- Domanico RS, Waldman JA, Lester LA, McPhillips HA, Catrambon JE, Covert RE. Prophylactic indometacin reduces the incidence of pulmonary hemorrhage and patent ductus arteriosus in surfactant treated infants < 1250 gr. Pediat Res, 1994; 32: 331-36. 
30.- González A, Hummier H, Sonseko IRS, Chandar J, Ronald N, Goldera N, Bancalari E. Surfactant administration, patent ductus arteriosus and pulmonary hemorrhage in premature infants <1000 gr. Pediatr Res, 1994; 35: 227-32. 
31.- Haworth SG, Hislop AA. Adaptation of the pulmonary circulation to extrauterine life in the pig and its relevance to the human infant. Cardiovas Res, 1981; 15: 108-19. 
32.- Heymann MA. Regulation of the pulmonary circulation in the perinatal period and in children. Intensive Care Med, 1989; 15: S9-S12. 
33.- Teitel DF, Iwamoto HS, Rudolph AW. Changes in the pulmonary circulation during birth-related events: Pediatr Res, 1990; 27: 372-78. 
34.- James W, Ziegler D, Ivy D, Kinsella JP, Ubman SH. Función del óxido nítrico, la endotelina y la prostaglandina en la transición de la circulación pulmonar. Clin Perinatol, 1995; 2: 365-81. 
35.- Steinhorn RH, Millard SL, Morin FC. Hipertensión pulmonar persistente del recién nacido, óxido nítrico y endotelina en la fisiopatología y tratamiento. Clin Perinatol, 1995; 2: 381-402. 
36.- Siassi B, Goldberg SJ, Emmanouilides GC, Higashino SM, Lewis E. Persistent pulmonary vascular obstruction in newborn infants. J Pediatr, 1976; 78: 610-15. 
37.- Geggel RL, Reid IM. The estructural basis of PPHTN. Clin Perinatol, 1984; 11: 525-96. 
38.- Zellers T, Gutgesell HP. Non invasive estimation of pulmonary artery pressure. J Pediatr 1989; 114: 735-41. 
39.- Runkle B, Bancalari E. Acute cardiopulmonary effects of pancuronium bromide in mechanically ventilated newborn infant. J Pediatr, 1984; 104: 614-17. 
40.- Ferrara B, Johnson DE, Chang PN, Thompson TR. Efficacy and neurologic outcome of profound hypocapnic alkalosis for the treatment of persistent pulmonary hypertension. J Pediatrics, 1984; 81: 457-61. 
41.- Bifano EM, Pfannestiel A. Duration of hyperventilation and outcome in infants with persistent pulmonary hypertension. Pediatrics, 1988; 81: 657-61. 
42.- Drummond WH, Gregory GA, Heymann MA, Phibbs RA. The independent effects of hypertension. J Pediatr, 1981; 98: 603-11. 
43.- Hegyi R, Hiatt IM. Tolazoline and dopamine therapy in neonatal hypoxia and pulmonary vasospasm. Acta Paediatr Scand, 1980; 60: 101-3. 
44.- Bifumy E, Kaveey RE, Pergolizzi J, Slagle T, Berfstron W. The cardiopulmonary effects of calcium infusion in infants with persistent pulmonary hypertension of the newborn. Pediatr Res, 1989; 25: 262-65. 
45.- Stevenson DK, Johnson JD, Malachowski N. Refractary hypoxemia associated with neonatal pulmonary disease. The use limitations of tolazoline. J Pediatr, 1979; 95: 595-99. 
46.- Soifer SL, Clyman RI, Heymann MA. Effects of prostaglandin E2 on pulmonary arterial pressure and oxigenation in newborn infants with persistent pulmonary hypertension. J  Pediatr, 1988; 112: 774-77. 
47.- Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet, 1992; 340: 818-19. 
48.- Zayek M, Cleveland D, Morin FC. Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled oxide nitric. J Pediatr, 1993; 122: 743-50. 
49.- Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr, 1993; 123: 103-8. 
50.- Palmer RNJ, Ferrige AG, Moncada SA. Nitric oxide relase accounts for the biological activity of endothelium derived relaxing factor. Nature, 1987; 327: 525-26. 
51.- Bartlett RH, Gazzaniga AB, Tooumasian J, Corvin AG, Roloff D, Ruker R. Extracorporeal membrane oxygenation (ECMO) in neonatal respiratory failure. Ann Surg, 1986; 204: 236-45. 
52.- Rourke PP, Crome RK, Vacarti JP, Ware JH, Lillehei CW, Pered RB, Epstein MF. Extracorporeal membrane oxigenation and convetional medical therapy in neonates with persistent pulmonary hypertension of the newborn: A prospective randomized study. Pediatrics, 1984; 84: 957-63. 
53.- Walsh-Sukys MC, Cornell DJ, Houston LN, Keszler M, Kanto WP. Tratamiento de la hipertensión pulmonar persistente del recién nacido sin hiperventilacion: valoración de la difusión de los tratamientos innovadores. Pediatrics (ed esp), 1994; 38: 177-81. 
54.- Pérez Rodríguez J. Problemas respiratorios del recién nacido. En: Hernández M: Tratado de pediatria 2ª Ed. Madrid. Ed. Díaz Santos, 1994: 216-35. 
55.- Fox WW, Spitzer AR. Shuntcack JG. Positive pressure ventilation: Pressure and time cycled ventilators. En: Gold-Smith JP, Karotkin EH: Assisted ventilation of the neonate, 2ª ed. Filadelfia. WB Saunders Co, 1986: 146-70. 
56.- Borg SJ, Bing DR, Mammel ML, Husen E, Gordon M, Sing V.Conventional infant ventilator at unconventional rates. Pediatrics, 1984; 74: 487-92. 
57.- Pohlandt F, Saule H, Schroder H, Leonhardt A. Decreased incidence of extra-alveolar air leakage or death prior to air leakage in high versus low rate positive pressure ventilation: results of a randomized seven centre trial in preterm infants. Eur J Pediatr, 1992; 151: 904-9.
58.- Sinkin RA, Phelps DL. Nuevas estrategias para evitar la displasia broncopulmonar. Clin Perinatol, 1987; 3: 623-46. 
59.- Coté CJ. Protocolos de sedación. ¿Porqué tantas variaciones?. Pediatrics, 1994; 38: 3: 131-33. 
60.- Bernstein G, Cleary JP, Heldt GP, Rosas JF, Schellenber LD, Mannino FL. Response time and reliability of three neonatal patient-triggered ventilators. Am Rev Respir Dis, 1993; 148: 358-64. 
61.- Hird MF, Greenough A. Comparison of triggering systems for neonatal patient triggered ventilation. Arch Dis Child, 1991; 66: 426-28. 
62.- Mitchell A, Greenough A, Hird MF. Limitations of patient triggered ventilation in neonates. Arch Dis Child, 1989; 64: 924-29. 
63.- Amitay M, Etches PC, Finer NN, Maidens JM. Synchronous mechanical ventilation of the neonate with respiratory disease. Crit Care Med, 1993; 21: 118-24. 
64.- Chan V, Greenough A. Randomized controlled trial of weaning by patient triggered ventilation or convencional ventilation. Eur J Pediatr, 1993; 152: 570-572. 
65.- Visveshwara N, Freeman B, Peck M, Caliwag W. Patient-triggered synchronized assisted ventilation of newborns: report of preliminary study and three yerars experience. J Perinatol, 1991; XI: 347-54. 
66. Bancalari E, Goldberg RN. Ventilación de alta frecuencia en el neonato. Clin Perinatol, 1987; 3: 605-22. 
67.- Bartlett RH, Roloff DW, Cornell RG. Extracorporeal circulation in neonatal respiratory failure; a prospective randomized study. Pediatrics, 1985; 76: 479-87. 
68.- Short BL, Miller MK, Anderson KD. Oxigenación por membrana extracorpórea en el tratamiento de la insuficiencia respiratoria del neonato. Clin Perinatol, 1987; 3: 771-82. 
69.- O'Rourke PP, Crone RK, Vacanti JP. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics, 1989; 84: 957-63. 
70.- Wright LL. Report of the workshop on diffusion of ECMO technology. NHI publication nª 93-3399. US-Department of health and human services. January, 1993. 
71.- Schumacher RE. Extracorporeal membrane oxygenation. Will this therapy continue to be as efficacious in the future?. Update Neonatol, 1993; 40: 1005-22. 
72.- Aresman and Cornich: Extracorporeal life support. Boston. Blackwell Scientific Publications. 1993.
73.- Shanley CL, Hirschl RB, Schumacher RE. Extracorporeal life support for neonatal respiratory failure. A 20 year experience. Ann Surg, 1994; 220: 269-82. 
74.- Shaffer TH, Wolfson MR, Clark LC. Liquid ventilation. Pediatr Pulmonol, 1992; 14: 102-9. 
75.- Greespan JS, Wolfson MR, Rubinstein SD, Shaffer TH. Liquid ventilation of human preterm neonates. J Pediatr, 1990; 117: 106-11. 
76.- Younes M. Proportional assit ventilation, a new approach to ventilatory support: theory. Am Rev Respir Dis, 1992; 145: 114-20. 
77.- Ravencraft SA, Burke WC, Nahum A, Adams AB. Tracheal gas insufflation during pressure-control ventilation. Effect of catheter position, and flow rate. Am Rev Respir Dis 1992; 146: 1411-18. 
78.- Bancalari A, Bancalari E, Hehre D, Suguihara C, Gerhardt T. Effect of distal endotracheal bias flow on PaCO2 during frequency oscillatory ventilation. Biol Neonate, 1988; 53: 61-67. 
79.- Feeman JE. Prenatal and Perinatal Factors Associated with Brain Disorders. Us Dep of Healt an Human Services Publications. No (NH). National Institute of Heath, 1985;85: 1149. 
80.- American Academy of Pediatrics Committee on Fetus and Newborn: Use and abuse of the Apgar Score. Pediatrics. 1986;78: 1148-51. 
81.- Brian S, Haverkamp A, Merestein C. Defnción de la asfxia pernatal aguda. Clin Perinat 1993 : 2: 311-26. 
82.- American Academy of Pediatrics. College of Obstetricians and Gynecologits.; Relations between perinatal factors and neurologic outcome. En: Poland RL, Feeman RK (ed): Guidelines for Perinatal Care, 3ªed. Grove Village. ELK ed, 1992: 221-24. 
83.- Block BS, Schlaffer DH, Wentwort RA. Intrauterine asphyxia and the breakdown of physiologic circulatory compensation in fetal sheep. Am J Obstet Gynecol, 1990; 162: 1325-31. 
84.- Williams C, Mallard C, Tavw C, Gluckmand P. Fisiopatología de la asfixia perinatal. Clin Perinatol, 1993; 2: 305-25. 
85.- Itskovitz J, La Gamma EF, Rudolph AM. Effects of cord compression on fetal blood, flow distribution and O2 delivery. Am J Physiol, 1987; 252: 100-109. 
86.- Rosenberg AA, Jomes M Jr. Traystman RJ. Response of cerebral blood flow to changes in PCO2 in fetal, newborn, and adult sheep. Am J Physiol, 1982; 242: 862-66. 
87.- Lou HC, Lassen NA, Fris-Hansen B. Impaired autorregulation of cerebral blood flow in the distressed newborn infant. J Pediatr, 1979; 94: 118-21. 
88.- Mathew OP, Bland H, Boxerman SB. CSF Lactate levels in high risk neonates with and without asphyxia. Pediatrics, 1980; 66: 224-7. 
89.- Fernández F, Verdún A, Quero J. Cerebrospinal fluid lactate levels in term infants with and without perinatal asphyxia. Pediatr Neurol 1986; 2: 39-42. 
90.- Harknes RA, Simmonds RJ, Coade SB. Ratio of concentration of Hypoxanthine to creatinine in urine from newborn infant: a possible indicator for the metabolic damege due to hypoxia. Br J Obstet Gynaecol, 1983; 90: 447-52. 
91.- Raichle ME. The Pathophysiology of brain ischemia. Ann Neurol 1983; 13: 2-10. 
92. Golplerud JM, Wagerle LC, Delivoria Apadopoulos M. Regional cerebral blood flow response during and after acute asphyxia in newborn piglets. J Appl Physiol, 1989; 66: 2827-32. 
93.- O'Shaughnessy CT, Lythogoe DJ, Butcher SP. Effects of hypoxia on fetal rat brain metabolism studied in utero by P-NMR spectroscopy. Brain Res, 1991; 551: 334-37. 
94.- De Boer J, Klein HC, Postema F. Rat striatal cation shifts reflecting hypoxic-ischemic damage can be predicted by online impedance measurements. Stroke, 1989; 20: 1377-82. 
95.- Kellmer I, Hagberg H. Perinatal brain damage, excitatory amino acids and oxygen derived free radicals. En: Van Geijin HP, Copray FJ; A Critical appraisal of fetal surveillance. Amsterdam. Elsevier Science, 1994: 604-14. 
96.- Page O, Martin J, Palmer S. Correlation of neonatal acid-base status with Apgar scores and fetal heart rate tracings. Am J Obstet Gynecol, 1986; 154: 1306-11. 
97.- Manning F, Morrison L, Lange I. Fetal assessment based on fetal biophysical profile scoring: Experience in 12.620 refered high risk pregnancies. I Perinatal mortality by frecuency and etiology. Am J Obstet Gynecol, 1985; 151: 343-49.
98.- Manning F, Morrison L, Harman C. Fetal assessment based on fetal biophysical profile scoring: Experience in 12.620 refered high risk pregnancies. II an analysis of false negative fetal deaths. Am J Obstet Gynecol, 1987; 157: 880-87. 
99.- Willcourt RJ, King J, Indyk L. The relationship of fetal heart rate patherns to fetal transcutaneus PO2. Am J Obstet Gynecol, 1981; 140: 760-69, 
100.- Hammacher K, Huter K, Bokelman J. Fetal heart frecuency and perinatal condition of the fetus and newborn. Gynecologia, 1968; 166: 349-60. 
101.- Caldeyro-Barcia R. Monitorización fetal. Monografía C.L.A.P. Montevideo, 1976. 
102.- Vintzileos A, Campbell W, Ingardia C. The fetal biophysical profil and its predictive value. Obstet Gynecol, 1983; 62: 271-78. 
103.- Vintzileos A, Gaffney A, Salinger L. The relationship betwen fetal biophysical profile and cord pH in patients undergoing cesarean section before the onset of labor. Obstet Gynecol, 1987; 70: 196-201. 
104.- Smith C, Phelan J, Broussard P. Fetal acustic stimulation testing III. Predictive value of a reactive test. J Reprod Med, 1988; 33: 217-21. 
105.- Gallo M, Chala J, Gómez M. NST versus Doppler en el diagnostico del estado fetal intraútero. Actas Reunión Nacional Medicina Perinatal, 1990: 46. 
106.- Morrow B, Ritchie K. Ultrasonidos Doppler y velocimetría fetal: su importancia en obstetricia. Clin Perinatol, 1989; 3: 837-45. 
107.- Soothill P, Nicolaides K, Rodeck C . The effect of gestacional age on blood gas acid-base values in human pregnancy. Fetal Therapy, 1986; 1: 168-75. 
108.- Soothill P. Cordocentesis: importancia en la valoracion del estado fetal. Clin Perinatol, 1989; 3: 819-36. 
109.- Fee S, Malee K, Deddish R. Severe acidosis and subsecuent neurologic status. Am J Obstet Gynecol, 1990; 162: 802-07. 
110.- Quero J. Asfixia perinatal y reanimacion del recien nacido. En: Hernández M. Tratado de Pediatria, 2ª ed. Madrid. Editorial Diaz Santos S.A., 1995: 191-215. 
111.- Volpe JJ. Hypoxic-Ischemic encefapalopathy. En: Volpe JJ. Neurology of the newborn. Philadelphia. WP Saunders, 1995: 221-369. 
112.- Saugstad OD, Zieger MG, Keslel B. Correlation of plasma hypoxanthine and catecholamine levels in the umbilical vein. J Perinatal Med, 1986; 14: 339-41. 
113.- Loscertales M, Martínez ML, Navarrete C, Molina JA. Control osmolar y arginina- vasopresina en niños nacidos después de un sufrimiento feto-neonatal agudo. An Esp Pediatr, 1990; 32: 49-52. 
114.- Narbona E. Maldonado J, Nieto GM. Concentraciones plasmáticas de péptido natriurético atrial, vasopresina y aldosterona en sangre de cordon umbilical: sus correlaciones con la asfixia perinatal. An Esp Pediatr, 1990; 32: 53-6. 
115.- Bacigalupo G, Langner K, Schmidt S. Plasma immunoreactive beta-endorphin, ACTH and cortisol concentrations in mothers and their neonates immediately after delivery: their relationship with the duration of labor. J Perinat Med, 1987; 15: 45-52. 
116.- Bayes R, Mojón ML, Macias F. Plasma beta-endorphin concentration in newborn infants and relationship with intrapartum hypoxia. En: Grauel EL. Research in perinatal medicine. Leipzig. VEG Georg Thieme, 1986: 267-73. 
117.- Ruth V, Autti-Ramo, Granstrom ML. Prediction of perinatal brain damage by cord plasma erytropoietin and hypoxanthine values. J Pediatr, 1988; 113: 880-85. 
118.- Laudignon N, Beharry K, Rex J. Effect of adenosine on total and regional cerebral blood flow in the newborn piglet. J Cereb Blood Flow Metab, 1990; 10: 392-98. 
119.- Roy MW, Dempsey RJ, Cowen DE. Thromboxane synthetase inhibition with imidazole increases blood flow in ischemic penumbra. Neurosurgery, 1988; 22: 317-23. 
120.- Archer LN, Levene MI, Evans DM. Cerebral artery Doppler ultrasonography for prediction of outcome after perinatal asphyxia. Lancet, 1986; 2: 1116-18. 
121.- Fernández F, Verdún A, Quero J. CPK-BB sérica en la valoración del daño cerebral en el recién nacido a término. Acta Paediatr Scand (ed. ep), 1987; 4: 999-1003. 
122.- Ruth VJ,  Prognostic value of Creatin-Kinase BB isoenzymes in high-risk newborn infants. Arch Dis Child, 1989; 64: 563-68. 
123.- García Alix A, Cabañas F, Pellicer A, Quero J. Neuron-Specific Enolase and Myelin Basic Protein: Relationship of cerebrospinal fluid concentrations to the neurologic of aphyxiated full-term infants. Pediatrics, 1994; 93: 234-40
124.- Oriot D, Betremieux P, Baumann N. CSF ascorbic acid and lactate levels after neonatal asphyxia: preliminary results. Paediatr, 1992; 81: 845-46. 
125.- Klempt ND, Sirimanne E, Gunn AJ. Hypoxia-ischemia induces transforming growth factor B mRNA in the infant rat brain. Mol Brain Res, 1992;13: 93-101. 
126.- Gluckman PD, Klempt ND, Guan J.. A role for IGF-I in the rescue of CNS neurons following hypoxia-ischemic injury. Biochem Biophys Res Commun, 1992; 182: 593-99. 
127.- Martin DJ, Hill A, Fitz CR. Hypoxic-ischemic cerebral injury in the neonatal brain. A report of sonographic features with computed tomographic correlation. J Pediatr Radiol, 1983; 13: 307-12. 
128.- Siegel MJ, Skackelford GD, Perlman JM. Hypoxic-ischemic encephalopathy in term infants. Diagnosis and prognosis evaluated by ultrasound. Radiology, 1984; 152: 395-99. 
129.- Shankaran S, Kottamasu SR, Kuhns L. Sonografía, tomografía computarizada y tomografía computarizada por emisión de fotón único del cerebro en recién nacidos a término con asfixia perinatal. Clin Perinatol, 1993; 2: 397-410. 
130.- Goplerud JM, Papadopoulos MD. Resonancia magnética nuclear y espectroscopia después de la asfixia. Clin Perinatol, 1993; 2: 365-86. 
131.- Fernandez F, Toledano M. de la Torre MC. Aspectos actuales y tratamiento de las convulsiones neonatales. Rev Esp Pediatr, 1991; 47: 249-56. 
132.- Donn SM, Goldstein GW, Schork MA. Neonatal hypoxic-ischemic encephalopathy. Current management practices. J Perinatol, 1988; 8: 49-52. 
133.- Palmer C, Roberts RL. Reduction of perinatal hypoxic-ischemic injury with deferoxamine treatment during recovery. Pediatr Res, 1992; 31: 351-56. 
134.- Palmer C, Roberts RL. Reduction of perinatal brain damage with oxypurinol treatment durig recovery. Pediatr Res, 1991; 29: 362-68. 
135.- Palmer C, Vannucci RC, Towfighi J. Reduction of perinatal hypoxic ischemic brain damage with allopurinol. Pediatr Res, 1990; 27: 332-36. 
136.- Palmer C, Vannucci RC. Nuevas terapéuticas posibles para la hipoxia e isquemia cerebrales perinatales. Clin Perinatol, 1993; 2: 425-44. 
137.- Moro M. Infección bacteriana en el recién nacido. An Esp Peditr 1992; 49; 174-90.
138.- Elorza MD, Omeñaca A. Sepsis neonatal. Incidencia y resultados sobre una población de 45.731 recién nacidos vivos. An Esp Pediatr, 1987; 26: 319-27.
139.- Krauel X, Lizarraga I, Iriondo M. Estudio epidemiológico y diagnóstico de la sepsis neonatal. Libro de Ponencias de la XII Reunión Nacional de Medicina Perinatal. Tenerife, 1991: 30-45.
140.- Quero J. Infecciones en el recién nacido. En: Hernandez M. Tratado de Pediatría,2ª ed. Madrid. Ed. Diaz de Santos S.A., 1994: 286-18.
141.- Baker CL. Grupo B-Streptococcal infections in neonates. Pediatr Rev, 1979: 95: 89-98.
142.- Gotoff SP. Infecciones del recién nacido. En: Behrman RE, Nelson. Tratado de Pediatria, 14ªed. Madrid. Interamericana-McGraw-Hill, 1992: 595-12.
143.- Bosch J, Borja F, Alvarez E. Sepsis y meningitis neonatales. Enf Infec Microbiol Clin, 1989; 1: 40-43.
144.- García MJ, Salas A, Peña P, Quero J. Sepsis por estafilococo coagulasa negativo en recién nacidos portadores de catéteres vasculares centrales. An Esp Pediatr, 1990; 32: 518-22.
145.- StGeme III JW, Harris MC. Infección por estafilococo coagulasa negativo en el recién nacido. Clin Perinatol, 1991; 2: 287-308.
146.- Gerdes JS. Método clinicopatológico para el diagnóstico de sepsis neonatal. Clin Perinatol, 1991; 2: 365-86.
147.- Manroe BL, Weinberg AG, Rosenfeld CR. The neonatal blood counting in health and disease. Reference values for neutrophilic cells. J Pediatr, 1979: 95: 89-94.
148.- Rodwell RL, Leslie AL, Tudehope DI. Early diagnosis of neonatal sepsis using a hematologic scoring system. J Pediatr, 1988; 12: 761-7.
149.- Domenech E, Padilla ML, Igea M. Valoración de la proteina C reactiva en el diagnóstico precoz de sepsis neonatal. Influencia en el tipo de germenes y de otros factores. Rev Esp Pediatr, 1994; 4: 305-13.
150.- Pourcyrous M, Bada HS, Korones SB. Significance of serial C Reactive Protein responses in neonatal infection and other disorders. Pediatrics, 1993; 92: 431-35.
151.- Rabalais GP, Bronfin DR, Daum RS. Evaluation of a commercially available latex agglutination test for rapid diagnosis of Group B streptococcal infection. Pediatr Infect Dis J, 1987; 6: 177-80.
152.- Siegel JD, Mc Cracken GH. Sepsis neonatorun. N Egl J Med 1981; 304: 642-47.
153.- Suffredini AF. Current prospects for the treatment of clinical sepsis. Crit Care Med, 1994; 22: s12-s18.
154.- Sáez-Llorens X,Mc Cracken GH. Sepsis syndrome and sepsis shock in pediatrics: Current concepts of terminology, pathophysiology and management. J Pediatr, 1993; 123: 497-507.
155.- Adams HR, Baxter CR, Parker JL. Reduction of intrinsic contractile reserves of the left ventricle by E.coli endotoxin shock in guinea-pigs. J Biol Cell Cardiol, 1985; 17: 575-85.
156.- Cabal LA, Siassi B, Cristofanic C. Cardiovascular changes in infants with beta hemolytic streptococcus sepsis. Crit Care Med, 1990; 18: 715-18.
157.- Miall-Allen VM, Whitelaw AGL. Response to dopamine and dobutamine in the preterm infant less than 30 weeks gestation. Crit Care Med, 1989; 17: 1166-69.
158.- Gill AB, Weindling AM. Randomised controlled trial of plasma protein fraction versus dopamine in hypotensive very low birthweingh infants. Arch Dis Child, 1993; 69: 284-87.
159.- Roze JC, Tohier C, Maingueneau C. Response to dobutamine and dopamine in the hypotensive very pretern infant. Arc Dis Chil, 1993; 69: 59-63.
160.- Vendeyna TR, AndersonRJ. Are dopamine and/or dobutamine renoprotective in intensive care patients? Crit Care Med, 1994; 22: 1893-94.
161.- Meadows D, Edwards JD, Wilkins RG. Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med, 1988; 16: 663-66.
162.- Kliegman RM, Clapp DW. Principios racionales para la profilaxis y tratamiento de infecciones neonatales con inmunoglobulinas. Clin Perinatol, 1991; 2: 309-30.
163.- Cairo MS: Neutrophil transfusions in the treatment of neonatal sepsis. Am J Pediatr Hematol Oncol, 1989; 11: 227-34.
164.- Bifano EM, Curran TR. Minimización de la exposición a sangre donada en las unidades de cuidado intensivo neonatal. Clin Perinatol, 1995; 3: 615-29.
165.- Gillan ER, Christensen RD, Suen Y. A randomized, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis. Significant induction of peripheral and bone marrow neutrophilia. Blood, 1994; 84: 1427.
166.- Horowitz B, Chang MY. Preparation of fibronectin for therapeutic administration. En Mosher DF: Fibronectin. San Diego. Academic Press, 1989: 441.
167.- Polin RA. The role of fibronectin in diseases of newborrn infants and children. Rev Infect Dis, 1990; 12: s428.
168.- Figueras J, Jimenez R, Arcas R. Meningitis y ventriculitis en el recién nacido. An Esp Pediatr 1989; 31 (s38): 43-47.
169.- Moro M, Hindi B, Vargas F. Complicaciones y secuelas de la meningitis neonatal. An Esp Pediatr, 1989; 31 (s38): 48-52.
170.- Lebel MH. Meningitis. En: Oski FA. Principles and practice of pediatrics. Filadelfia JB Lippincott Co, 1994: 525-28.
171.- Huslan RHA. Neurological complications of neonatal bacterial meningitis. Int Pediatr 1987; 2: 100-108.
172.- Guzmán JM, Huertas MD, Fernández F, Zapatero M. Valor de la ecografía cerebral en el diagnóstico y seguimiento de la infección perinatal. Libro de Ponencias IV Jornadas de Medicina Perinatal. Granada, 1988: 77-103.
173.- Párraga MJ, Sánchez R, Fernández F. Infarto cerebral secundario a meningitis y ventriculitis en el periodo neonatal. Rev Esp Pediatr. 1996; 52: 361-364.
174.- Noguer A,  Echebarria J, Lande J. La ecografía cerebral en la meningitis del neonato y lactante. An Esp Pediatr, 1985; 22: 12-26.
175.- Jacobs RF. Cefotaxime treatment of gram negative enteric meningitis in infants and children. Drugs, 1988; 35: 185-89.
176.- Tessin I, Trollforks B, Thiringer K. Ampicilin-aminoglycoside combinations as initial treatmen for neonatal septicaemia or meningitis. Ac Paediatr Scand, 1991; 80: 911-16.
177.- Odio CM, Faingezicht I, Paris M, McCracken GH. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med, 1991; 324: 1525-31.
178.- Quero J. Problemas hematológicos en el recién nacido. En: Hernández M. Pediatría, 2ª ed. Madrid. Ed. Díaz Santos, 1994: 260-285.
179.- Oski FA. The erytrocyte and its disorders. En: Nathan DG y Oski FA. Hematology of infancy and childhood. Filadelfia. Saunders Co, 1993: 18-43.
180.- Werner EJ. Policitemia e hiperviscosidad neonatales. Clin Perinatol, 1995; 3: 651-67
181- Jiménez R, Figueras J. Enfermedad hemolítica del recién nacido. Anemias y poliglobulias. En:  Cruz M: Tratado de Pediatría, 7ª ed. Barcelona. Espaxs, 1994: 204-19.
182.- Behrman RE. Plétora neonatal. En: Nelson: Tratado de Pediatría, 14ª ed. Madrid. McGraw-Hill, 1992: 583-84.
183.- Oh W. Neonatal polycythemia and hyperviscosity. Pediatr Clin North Am, 1986; 33: 523-35.
184.- Jiménez R, Figueras J, Botet F. Poliglobulia neonatal. En: Jiménez R, Figueras J, Botet F. Neonatología. Procedimientos diagnósticos y terapéuticos. Barcelona. Espaxs, 1995: 516-518.
185.- Phibbs RH, Shannon KM. Hematologic problems. En: Klaus Fanaroff. Care of the high risk neonate. Filadelfia. Saunders Co, 1993: 397-408.
186.- Díaz B, León MC, Escribá R. Trastornos hematológicos del recién nacido. En: Zafra MA, Calvo C, García ML, Baquero F, Arribas A, Jiménez J, Bueno M. Manual de diagnóstico y tratamiento en Pediatría, 3ª ed. Madrid. Publires, 1996: 277-279.
187.- Jiménez R, Figueras J, Botet F. Anemia en el recién nacido. En: Jiménez R, Figueras J, Botet F. Neonatología. Procedimientos diagnósticos y terapéuticos. Barcelona. Espaxs, 1995: 511-516.
188.- Manchón GJ. Hematología perinatal. En: Natal A, Prats J: Manual de neonatología. Madrid. Mosby/Doyma, 1996: 165-72.
189.- Zipursky Z, Bowman JM. Isoinmune hemolityc diseases. En: Nathan DG y Oski FA. Hematology of infancy and childhood. Filadelfia. Saunders Co, 1993: 44-73.
190.- Domenech E. Trastornos hemorrágicos en el recién nacido. En:  Cruz M: Tratado de Pediatría, 7ª ed. Barcelona. Espaxs, 1994: 179-86.
191.- Zafra MA, Rodríguez MM, De la Oliva P. Alteraciones de la hemostasia en el recién nacido. Pediatrika, 1993; 13: 17-25.
192.- Buchanan GR. Coagulation disorders in the neonate. Pediatr Clin North Am, 1986; 33: 203-14.
193.- Glader BE, Amylon MD. Hemostastic disorders in the newborn. En: Taeusch, Ballard, Avery. Diseases of the newborn. Filadelfia. Saunders Co, 1991: 777-93.
194.- Andrew M. The hemostatic system in the infant. En: Nathan DG y Oski FA. Hematology of infancy and childhood. Filadelfia. Saunders Co, 1993: 115-153.
195.- Burrows RF, Kelton JG. Trombocitopenia perinatal. Ciln Perinatol, 1995; 3: 733-54.
196.- Bussel J, Kaplan C, McFarland J. Recomendations for the evaluation and treatment of neonatal autoimmune and alloimmune thrombocytopenia. Thromb & Haemost, 1991; 65: 631-34.
197.- Editorial. Management of alloimmune neonatal thrombocytopenia. Lancet, 1989; i : 137-38
198.- Escribá RM, Quero J, Omeñaca F, Ramírez O, Magallón M. Enfermedades autoinmunes en medicina perinatal. Trombocitopenia neonatal autoinmune. An Esp Pediatr, 1985; 22: 13-17.
199.- Bussel JB. Management of infants of mothers with immune thrombocytopenic purpura. J Pediatr, 1988; 113: 497-99.
200.- Manco-Johnson M. Diagnosis and management of thromboses in the perinatal period. Seminars in Perinatology, 1990; 14: 393-96.
201.- Quero J. Hiperbilirrubinemia neonatal. En: Hernández M. Pediatría, 2ª ed. Madrid. Díaz Santos, 1994: 236-59.
202.-  Jiménez R, Figueras J, Botet F. Ictericia neonatal. En: Jiménez R, Figueras J, Botet F. Neonatología. Procedimientos diagnósticos y terapéuticos. Barcelona. Espaxs, 1995: 519-527.
203.- Lawrence M, Gartner MD. Ictericia neonatal. Pediatrics in Review, 1995; 16: 22-31.
204.- Durán C, López N, Hawkins F, Escribá R. Ictericia neonatal. En: Zafra MA, Calvo C, García ML, Baquero F, Arribas A, Jiménez J, Bueno M. Manual de diagnóstico y tratamiento en Pediatría, 3ª ed. Madrid. Publires, 1996: 304-08.
205.- Peterec MD. Management of neonatal Rh disease. Clinics in perinatolgy, 1995; 3: 561-85.
206.- Yao TC, Stevenson DK. Advances in the diagnosis and treatment of neonatal hyperbilirrubinemia. Clin Perinatol, 1995; 3: 741-753.
207.- García M, Romero J, Ledesma JM. Factores de riesgo en la ictericia de los recién nacidos sanos. Arch Pediatr, 1992; 43: 39-41.
208.- American Academy of Pediatrics. Provisional Committe on Quality Improvement ans subcommitte on hyperbilirrubinemia. Management of hyperbilirrubinemia in the healthy term newborn. Pediatrics, 1994; 94: 558-65.
209.- Newman TB, Maisels MJ. Evaluation and treatment in jaundice in the term newborn. A kinder gentler approach. Pediatrics, 1992; 89: 809-18.
210.- Aulfors M. Criteria for exchange transfusion in jaundice newborn. Pediatrics, 1994; 93: 488-94.
211.- Koh Th HG, Eyre JA, Aynsley-Green A. Neonatal hypoglycaemia: the controversy regarding definition. Arch Dis Child, 1988; 63: 1386-88.
212.- Heck LJ, Erenberg A. Serum glucose levels in term neonates during the first 48 hours of life. J Pediatr, 1987; 110: 119-22.
213.- Jiménez R, Figueras J, Botet F. Transtornos de la glucemia. En: Jiménez R, Figueras J, Botet F. Neonatología. Procedimientos diagnósticos y terapéuticos. Barcelona. Espaxs, 1995: 290-93.
214.- Raspall F. Problemas de adaptación metabólica del recién nacido. En: Natal A, Prats J: Manual de neonatología. Madrid. Mosby/Doyma, 1996: 115-25.
215.- Pildes RS, Pyati SP. Hypoglycemia and hyperglycemia in tyni infants. Clin Perinatol, 1986; 13: 351-75.
216.- Lucas A, Morley R, Cole TJ. Adverse neurodevelopmental outcome of moderate neonatal hypoglycemia. Br Med J, 1988; 297: 1304-08.
217.- Hawdon JM, Ward Platt MP, Aynsley-Green A. Prevention and management of neonatal hypoglycemia. Arch Dis Child, 1994; 70: 60-65.
218.- Sanjosé MA, López C, Joya G, Del Castillo F, Hawkins F. Hijo de madre de riesgo. En: Zafra MA, Calvo C, García ML, Baquero F, Arribas A, Jiménez J, Bueno M. Manual de diagnóstico y tratamiento en Pediatría, 3ª ed. Madrid. Publires, 1996: 291-304.
219.- Pérez Fernández JL, Delgado A, Crespo A. El hijo de madre diabética. MDP Pediatr, 1995; 93: 35-47.
220.- Ogata ES. Carbohydrate metabolism in the fetus and the neonate and altered neonatal glucorregulation. Pediatr Clin N Amer, 1986; 33: 25-45.
221.- Collins JE, Leonard JV, Teale D. Hyperinsulinemic hypoglycemia in small for dates babies. Arch Dis Child, 1990; 65: 1118-20.
222.- Collins JW, Hoppe M, Brown K, Edivin DV, Padbury J, Ogata ES. A controlled trial of insulin infusion and parenteral nutrition in extremely low birth weight infants with glucose intolerance. J Pediatr, 1991; 118: 921-27.
223.- Moya M. Trastornos del calcio. En: Jiménez R, Figueras J, Botet F. Neonatología. Procedimientos diagnósticos y terapéuticos. Barcelona. Espaxs, 1995: 294-96.
224.- Lynch RE. Ionized calcium: Pediatric perspective. Pediatr Clin N Amer, 1990; 37: 373-89.
225.- Porcelli PJ, Oh W. Effects of single dose calcium gluconate infusion in hypocalcemic preterms infants. Am J Perinatol, 1995; 12: 18-21.
226.- Loughead JL, Mimouni F, Tsang RC. Serum ionized calcium concentrations in normal infants. Am J Dis Child, 1988; 142: 516-18.
227.- Cook JS, Stone MS, Hansen JR. Hypercalcemia in association with subcutaneous fat necrosis of the newborn: Studies of calcium-regulating hormones. Pediatrics, 1992; 90: 93-5
228.- Harris SS, D'Ercole AJ. Neonatal Hyperparathyroidism: the natural course in the absence of surgical intervention. Pediatrics, 1989; 83: 53-6.
229.- Cooper L, Wetheimer J, Levy R, Brown E, Leboff M, Wilkinson R, Anast CS. Hiperparatiroidismo primario grave en un recién nacido, con padres emparentados que presentaban hipercalcemia, tratado mediante paratiroidectomía y autotrasplante heterotópico. Pediatrics (ed esp), 1986; 22: 96-100.
230.- Lutz P, Kane D, Pfersdorff A, Seiller F, Sauvage P, Levy JM. Neonatal primary hyperparathyroidism: total parathyroidectomy with autotransplantation of cryopreserved parathyroid tissue. Acta Paediatr Scand, 1987; 76: 579-84.
231.- Jiménez R, Figueras J, Botet F. Transtornos del magnesio. En: Jiménez R, Figueras J, Botet F. Neonatología. Procedimientos diagnósticos y terapéuticos. Barcelona. Espaxs, 1995: 296-98.
232.- Nelson N, Finnstrom O, Larsson L. Neonatal hyperexcitability in relation to plasma ionized calcium, magnesium, phosphate and glucose. Acta Paediatr Scand, 1987; 76: 579-84.
233.- Closa R. Enterocolitis necrosante. En: Natal A, Prats J: Manual de neonatología. Madrid.  Mosby/Doyma, 1996: 237-43.
234.- Stoll J Barbara. Epidemie of necrotizing enterocolitis. Clinics in Perinatol, 1994; 21: 205-18.
235.- Toulukian JR. Etiolgic role of circulation. En: Brown GE, Sweet YA: Neonatal necrotizing enterocolitis. New York. Grune & Stratton, 1981: 41-56.
236.- McKendrick W, Kaplan M. Necrotizing enterocolitis. New thoughts about pathogenesis and potential treatments. Pediatr Clin North Amer, 1994; 40: 1047-59.
237.- Gómez TM, García FE, País PE, Vela ND, Gallego PM, Ríos TJ, Pérez-Lafuente LG, Dargallo CT, Candal AJ. Enterocolitis necrotizante: revisión de 10 años. Cir Pediatr 1995; 8: 20-23.
238.- Samaniego M, Sánchez MR. CK-BB sérica. Marcador bioquímico en la enterocolitis necrotizante neonatal. An Esp Pediatr, 1996; 44: 577-80.
239.- Walsh MD, Kliegman RM. Necrotizing enterocolitis. Treatment base on staging criteria. Pediatr Clin North Am, 1986; 33: 179-201.
240.- Ein SH, Shandling B, Wesson D, Filler RM. A 13 years experience with peritoneal drainage under local anesthesia for necrotizing enterocolitis perforation. J Pediatr Surg, 1990; 25: 1034-37.
241.- Ade-Ajayi N, Kiely E, Drake , Wheeler R, Spitz L. Resection and primary anastomosis in necrotizing enterocolitis. J R Soc Med, 1996; 89: 385-88.
242.- Lamireau T, Llanas B, Chateil JF, Sarlangue J, Cavert-Jouanolou MH, Vergnes P, Galperine RI, Demarquez JL. Frequence accrue et difficultes diagnostiques des stenoses intestinales apres enterocolite ulceronecrosante. Arch Pediatr, 1996; 3: 9-15.
243.- Eibl MM, Wolf HM, Furnkranz H, Rosenkranz A. Prevention of necrotizing enterocolitis in low birth weight infants with IgA.IgG feeding. N Eng J Med, 1988; 319: 1-7.
244.- Halac E, Halac J, Begue E, Casanas JM, Indiveri DR, Petit JF, Figueroa MJ, Olmas JM, Rodríguez JA, Obregón RJ. Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis. A controlled trial. J Pediatr, 1990; 117: 132-8.
245.- Lucas A, Cole TJ. Brest milk and neonatal necrotizing enterocolitis. Lancet, 1990; 336: 1519-23.
246.- Foglia RP. Esophageal disease in the pediatric age group. Chest Surg Clin N Am, 1994; 4: 785-809.
247.- Casasa JM, López P, Blanco JA, Castellví A, Isnard R. Principales problemas quirúrgicos y ortopédicos en el recién nacido. En: Natal A, Prats J: Manual de neonatología. Madrid. Mosby/Doyma, 1996: 213-25.
248.- Spitz L, Kiely EM, Morecroft JA, Drake DP. Oesophageal atresia: at-risk group for the 1990s. J Pediatr Surg, 1994; 29: 723-5.
249.- Lindahl H, Rintala E, Malinen L, Lijala M, Sairanen H. Bronchoscopy during the first month of life. J Pediatr Surg, 1992; 27: 548-50.
250.- Spitz L, Kiely EM, Brereton RJ, Drake D. Management of esophageal atresia. Word J Surg, 1993; 17: 296-300.
251.- Crabbe DC, Kiely EM, Drake DP, Spitz L. Management of the isolated tracheo-oesophageal fistula. Eur J Pediatr Surg, 1996; 6: 67-9.
252.- Martínez-Frías FL. Gastroschisis: is the prevalence increasung?. Am J Med Genet, 1994; 49: 128-30.
253.- Fisher R, Attah A, Partinfton A, Dykes E. Impact of antenatal diagnosis on incidence and prognosis in abdominal wall defects. J Pediatr Surg, 1996; 31: 538-41.
254.- Petro JA, Niazi ZB. Immediate skin expansion: an old concept by a novel and inexpensive technique. Ann Plast Surg, 1996; 36: 479-84.
255.- Bax NM, van der Zee DC, Pull Ter Gunne AJ, Rovekamp MH. Treatment of giant omphalocele by enlargement of the abdominal cavity with a tissue expander. J Pediatr Surg, 1993; 28: 1181-4.
256.- Fonkalsrud EW, Smith MD, Shaw KS, Borick JM, Shaw A. Selective management of gastroschisis according to the degree of visceroabdominal disproportion. Ann Surg, 1993; 218: 742-7.
257.- Lacey SR, Carris LA, Beyer AJ III, Azizkhan RG. Bladder pressure monitoring significantly enhances care of infants with abdominal wall defects: a prospective clinical study. J Pediatr Surg, 1993; 28: 1370-5.
258.- Hrabovsky E. Hernia diafragmática. En: Blumer J: Gruñi práctica de cuidados intensivos en Pediatría, 3ª ed. San Louis. Mosby, 1993: 211-15.
259.- O'Toole SJ, Karamanoukian HL, Glick PL. Cardiopulmonary consequences of congenital diaphragmatic hernia. J Perinatol, 1996; 16: s34-9.
260.- O'Toole SJ, Karamanoukian HL, Morin FC, Holm BA, Egan EA, Azizkhan, Glick PL. Surfactant decreases pulmonary vascular resistance and increases pulmonary blood flow in the fetal lamb model of congenital diaphragmatic hernia. J Pediatr Surg, 1996; 31: 507-11.
261.- Figueras J, Sorni A, Botet F, Rodríguez JM, Jiménez R. Respuesta inmediata a la administración de óxido nítrico inhalado en un neonato con hernia diafragmática congénita e hipertensión pulmonar. An Esp Pediatr, 1996; 44: 70-2.
262.- Karamanoukian HL, Glick PL, Zayeck M. Steinhorn RH, Zwass MS, Fineman JR, Morin FC. Inhaled nitric oxide in congenital hypoplasia of the lungs due to diaphragmatic hernia or oligohydramnios. Pediatrics, 1994; 94: 715-8.
263.- Soto C, Murcia J, López JC, Salas S, Quero J, Lassaleta L, Tovar JA. Hernia diafragmática congénita: análisis de resultados y factores pronósticos previos al desarrollo de un programa de ECMO. An Esp Pediatr, 1996; 44: 568.72.
264.- Ford WD. Fetal intervention for congenital diaphragmatic hernia. Fetal Diagn Ther, 1994; 9: 398-408.
265.- Senzaki H, Tamura M, Sakakihara Y, Hishi T. A new protocol for the perinatal management of patients with congenital diaphragmatic hernia with severe hypoplastic lungs and its clinical application. Acta Paediatr Jon, 1994; 36: 497-500 (abstract).
266.- Karamanoukian HL, O'Toole SJ, Glick OL. "State-of-the-art" management strategies for the dfetus and neonate with congenital diaphragmatic hernia. J Perinatol, 1996; 16: s40-7.
267.- Norden MA, Butt W, McDougall P. Predictors of survival for infants with congenital diaphragmatic hernia. J Pediatr Surg, 1994; 29: 1442-6.